AMZN
Amazon.com, Inc.
AMZN has the edge over CLAR overall, supported by stronger valuation and stronger modeled upside.
CLAR
Clarus Corporation
CLAR offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
CLAR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Stable |
CLAR's revenue and balance sheet are currently stable, but its profitability and cash flow are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
CLAR PE Valuation
CLAR has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 29x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over CLAR on the outlook, with more favorable revenue expectations.
CLAR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CLAR to return to profit, with revenue holding steady. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over CLAR on earnings quality, reporting a profit while its opponent remains loss making.
CLAR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.18 | — |
| Q3 2026 | -$0.69 | +$1.43 |
| Q2 2026 | -$0.82 | +$1.34 |
| Q1 2026 | -$1.16 | +$0.92 |
| Q4 2025 | -$1.21 | +$0.16 |
| Q3 2025 | -$2.12 | -1731% |
| Q2 2025 | -$2.16 | -1300% |
| Q1 2025 | -$2.08 | -900% |
| Q4 2024 | -$1.37 | -$1.10 |
CLAR is still losing money, but far less than before: $0.69 per share over the past year, against $2.22 at its worst in late 2023.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over CLAR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over CLAR on profitability, with a higher operating margin.
CLAR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $71.2M | +2.7% |
| Q2 2026 | $56.2M | +1.6% |
| Q1 2026 | $61.9M | +2.5% |
| Q4 2025 | $65.4M | -8.4% |
| Q3 2025 | $69.3M | +3.3% |
| Q2 2025 | $55.2M | -2.2% |
| Q1 2025 | $60.4M | -13% |
| Q4 2024 | $71.4M | +1377% |
CLAR's revenue fell from its 2021 peak and has held roughly level since: $71M last quarter, up 2.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.7% | +9 points |
| Q2 2026 | 8.1% | +28 points |
| Q1 2026 | -9.8% | +1.4 points |
| Q4 2025 | -60% | +11 points |
| Q3 2025 | -4.4% | +3.6 points |
| Q2 2025 | -20% | -5.3 points |
| Q1 2025 | -11% | -1.4 points |
| Q4 2024 | -70% | +496 points |
CLAR's operating margin was 4.7% last quarter, up 9 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
CLAR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.4M | -$443K |
| Q2 2026 | $636K | +$11.9M |
| Q1 2026 | -$5.7M | -$2.4M |
| Q4 2025 | $11.6M | -19% |
| Q3 2025 | -$7M | +$2.4M |
| Q2 2025 | -$11.3M | -$10.6M |
| Q1 2025 | -$3.3M | +$15M |
| Q4 2024 | $14.4M | +8.2% |
CLAR has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
CLAR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -74K shares |
| 1 year | -0.3% | -107K shares |
| 3 years | +2.2% | +825K shares |
| 5 years | +5.9% | +2.1M shares |
| Available history | +23% | +7.2M shares |
CLAR has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $447,000 |
| Q1 2026 | $32,000 |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $42,000 |
| Q4 2024 | — |
CLAR spent $479,000 buying back its own shares over the past year, more than ten times what it spent the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CLAR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2022 | 2.9x | Moderate |
| Q2 2022 | 2.9x | Moderate |
| Q1 2022 | 3.2x | Elevated |
| Q4 2021 | 3.3x | Elevated |
| Q3 2021 | 5.8x | High |
| Q2 2021 | 0.7x | Very low |
| Q1 2021 | 1.2x | Healthy |
| Q4 2020 | 1.3x | Healthy |
CLAR's net debt is about 2.9 years of its operating earnings (EBITDA), down from 5.8 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
CLAR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 80.0 | Overbought |
| Stochastic | 89.2 | Overbought |
CLAR's weekly RSI is 80 (overbought) and its Stochastic is 89 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
CLAR PE vs Consumer Cyclical Sector
| Metric | CLAR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CLAR has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over CLAR on trend strength, trading above more of its moving averages.
CLAR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.07 | 27% above |
| 20 week MA | $3.74 | 38% above |
| 50 week MA | $3.38 | 53% above |
| 100 week MA | $3.58 | 44% above |
| 200 week MA | $5.20 | 0.6% below |
CLAR has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 0.6% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
CLAR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.6 | $15.4 | +13% |
| 2021 | $15.4 | $26.7 | +73% |
| 2022 | $26.7 | $7.15 | -73% |
| 2023 | $7.15 | $6.90 | -3.5% |
| 2024 | $6.90 | $4.54 | -34% |
| 2025 | $4.54 | $3.38 | -26% |
| 2026 YTD | $3.38 | $5.17 | +53% |
CLAR has the edge over AMZN on returns for 2026, with the stronger performance.